文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis.

作者信息

Foong Yi Chao, Merlo Daniel, Gresle Melissa, Zhu Chao, Buzzard Katherine, Lechner-Scott Jeannette, Barnett Michael, Taylor Bruce V, Kalincik Tomas, Kilpatrick Trevor, Darby David, Dobay Pamela, van Beek Johan, Hyde Robert, Simpson-Yap Steve, Butzkueven Helmut, van der Walt Anneke

机构信息

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Alfred Health, Melbourne, Victoria, Australia.

出版信息

Eur J Neurol. 2025 Jan;32(1):e70000. doi: 10.1111/ene.70000.


DOI:10.1111/ene.70000
PMID:39714314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11665050/
Abstract

BACKGROUND: Upper limb dysfunction is a common debilitating feature of relapsing-remitting multiple sclerosis (RRMS). We aimed to examine the longitudinal trajectory of the iPad®-based Manual Dexterity Test (MDT) and predictors of change over time. METHODS: We prospectively enrolled RRMS patients (limited to Expanded Disability Status Scale (EDSS) < 4). Longitudinal data was analysed using mixed-effect modelling and latent class mixed models. We then examined whether group membership in latent classes predicted confirmed slowing in MDT. RESULTS: Seven hundred and twenty-one participants had complete data for analysis. At a population level, MDT remained stable over time. No practice effect was seen. Baseline disability and T2 lesion volume were the strongest predictors of longitudinal MDT performance. We identified two latent class trajectories of MDT. The slower latent class was typified by greater variability and a weak association with confirmed worsening of MDT and EDSS. When compared to trajectory analysis stratified by baseline MDT, latent class analysis (LCA) was able to identify those at greater risk of confirmed slowing, signifying the importance of latent processes in upper limb function in pwMS. CONCLUSION: In this cohort of mild to moderate RRMS, MDT scores remained stable over time with no evidence of a practice effect at a population level. Trajectory analysis based on LCA identified a cohort with greater variability and risk of disability progression and domain specific worsening. Our findings demonstrate the importance of latent processes in determining upper limb function in pwMS.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/e3a515cf5eb4/ENE-32-e70000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/665b7ef64341/ENE-32-e70000-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/afc5b51b3980/ENE-32-e70000-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/ce5b1cf55f84/ENE-32-e70000-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/b6219d9b9a3b/ENE-32-e70000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/f28277152d7c/ENE-32-e70000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/c354f16b0b64/ENE-32-e70000-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/e3a515cf5eb4/ENE-32-e70000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/665b7ef64341/ENE-32-e70000-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/afc5b51b3980/ENE-32-e70000-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/ce5b1cf55f84/ENE-32-e70000-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/b6219d9b9a3b/ENE-32-e70000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/f28277152d7c/ENE-32-e70000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/c354f16b0b64/ENE-32-e70000-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b91/11665050/e3a515cf5eb4/ENE-32-e70000-g003.jpg

相似文献

[1]
Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis.

Eur J Neurol. 2025-1

[2]
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis.

Ann Clin Transl Neurol. 2025-4

[3]
Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis.

Neurology. 2021-11-16

[4]
Naturally occurring change in Multiple Sclerosis Walking Scale-12 scores over time in multiple sclerosis.

Neurodegener Dis Manag. 2018-10

[5]
Trunk control: The essence for upper limb functionality in patients with multiple sclerosis.

Mult Scler Relat Disord. 2018-6-28

[6]
Distribution and relation of two arm function tests, Box and Blocks test and Nine Hole Peg test, across disease severity levels and types of multiple sclerosis.

Mult Scler Relat Disord. 2022-3

[7]
Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.

Health Technol Assess. 2016-10

[8]
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials.

Neurology. 2025-5-27

[9]
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.

Neurology. 2016-11-8

[10]
Longitudinal analysis of retinal and choriocapillaris in patients with multiple sclerosis: a 3-year study.

J Neurol. 2025-3-1

引用本文的文献

[1]
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis.

Ann Clin Transl Neurol. 2025-4

本文引用的文献

[1]
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.

JAMA Neurol. 2023-11-1

[2]
The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.

Eur J Neurol. 2024-1

[3]
Smartphone monitoring of cognition in people with multiple sclerosis: A systematic review.

Mult Scler Relat Disord. 2023-5

[4]
The nine hole peg test as an outcome measure in progressive MS trials.

Mult Scler Relat Disord. 2023-1

[5]
Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests.

Mult Scler Relat Disord. 2022-2

[6]
MRI correlates of clinical disability and hand-motor performance in multiple sclerosis phenotypes.

Mult Scler. 2021-7

[7]
Ten-year disease progression in multiple sclerosis: walking declines more rapidly than arm and hand function.

Mult Scler Relat Disord. 2020-10

[8]
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data.

Neurology. 2019-10-22

[9]
Longitudinal assessment of hand function in individuals with multiple sclerosis.

Mult Scler Relat Disord. 2019-5-6

[10]
Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review.

PLoS One. 2019-2-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索